Gemelli Biotech

About:

Gemelli is a biotechnology company that specializes in the microbiome, and IBS diagnostics.

Website: https://www.gemellibiotech.com/

Top Investors: Cedars Sinai, CerraCap Ventures, Blue Ox Healthcare Partners, Carolina Angel Network

Description:

Gemelli is a biotechnology company that specializes in the microbiome, and IBS diagnostics. It strives to achieve a thriving global family of healthy individuals by unlocking the potential of the microbiome. The company is driven by its mission is to support the discovery of novel diagnostics and therapeutics for the human microbiome by bringing biotechnology innovations to market in a fiscally responsible and socially conscious way. The company was founded in 2018 and headquartered in North Carolina, United States.

Total Funding Amount:

$28.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Raleigh, North Carolina, United States

Founded Date:

2018-07-18

Contact Email:

hello(AT)gemellibiotech.com

Founders:

Ali Rezaie, Mark Pimentel, Matt Mitcho, Ruchi Mathur

Number of Employees:

11-50

Last Funding Date:

2022-06-22

IPO Status:

Private

Industries:

© 2025 bioDAO.ai